Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
World Journal of Urology|April 25, 2012
A switch from GnRH agonist to GnRH antagonist in castration-resistant prostate cancer patients leads to a low response rate on PSAAlexandra Masson-Lecomte, Laurent Guy, Philippe Pedron, et al.
The French Journal of Urology|June 26, 2026
Guidelines of the Oncology Committee of the French Association of Urology (CCAFU) and the Infectious Diseases Committee of the French Association of Urology (CIAFU) for Intravesical Instillation of Mitomycin C, Epirubicin, and BCG in NMIBCPriscilla Leon, Thibaut Long Depaquit, François Audenet, et al.
World Journal of Urology|November 14, 2019
Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter studyLouis Lenfant, Riccardo Campi, Jérôme Parra, et al.
Oncotarget|September 22, 2018
Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8<sup>+</sup> T cellsFrancois Desgrandchamps, Joel LeMaoult, Annabelle Goujon, et al.
Bladder Cancer (Amsterdam, Netherlands)|September 26, 2022
CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and PrognosisAlexandra Masson-Lecomte, Pascale Maillé, Silvia Pineda, et al.
World Journal of Urology|May 11, 2018
Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french studyLouis Lenfant, Gregory Verhoest, Riccardo Campi, et al.
World Journal of Urology|July 16, 2020
PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatmentMathieu Roumiguié, Eva Compérat, Léonor Chaltiel, et al.
BJU International|April 3, 2014
Early unclamping technique during robot-assisted laparoscopic partial nephrectomy can minimise warm ischaemia without increasing morbidityBenoit Peyronnet, Hervé Baumert, Romain Mathieu, et al.
European Urology Oncology|July 8, 2026
Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-makingConstance Thibault, Hélène Blons, Yves Allory, et al.
The French Journal of Urology|April 17, 2026
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French association of Urology for the management of adverse events and complications of BCGPriscilla Leon, Laura I Levi, Thibaut Long Depaquit, et al.
Pageof 10